Class Information
New Frontiers, New Challenges in STI Prevention and Treatment: Doxycycline Post-Exposure Prophylaxis and Multi-Drug Resistant Gonorrhea
OBJECTIVES
- Discuss management of patients at-risk for acquiring sexually transmitted infections (STIs) and Human Immune Deficiency Virus (HIV);
- Describe the management of STIs
- Compare benefits/risks of differing contraceptive methods for all patients;
- Identify ethical issues which apply to STI/HIV research and treatment;
- Discuss how issues of cultural competency impact on STI/HIV prevention outcomes;
- List 2 ways this sexual health assessment training will impact my team
**The highlighted objectives will be used for this occurrence but the rest of the objectives will be used for other lectures throughout the series.
Origination Date: 2/17/2022
Expiration Date: 2/17/2024
ACCREDITATION STATEMENTS:
|
|
In support of improving patient care, this activity has been planned and implemented by Centers for Disease Control and Prevention and STI/HIV Prevention Training Center at Johns Hopkins. The Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
|
CME: The Centers for Disease Control and Prevention designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAPA CME: Credit Designation Statement – Live
The Centers for Disease Control and Prevention has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
CNE: The Centers for Disease Control and Prevention designates this activity for 1.0 nursing contact hours.
CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer .1 CEU's for this program.
CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES®) and/or Master Certified Health Education Specialists (MCHES®) to receive up to 1.0 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 1.0. Continuing Competency credits available are 1.0. CDC provider number 98614.
For Certified Public Health Professionals (CPH)
The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 1.0 CPH recertification credits for this program.
DISCLOSURE: In compliance with continuing education requirements, all planners and presenters must disclose all financial relationships, in any amount, with ineligible companies over the previous 24 months as well as any use of unlabeled product(s) or products under investigational use.
CDC, our planners, and presenters wish to disclose they have no financial relationship(s) with ineligible companies with the exception of Dr. Hamill and he wishes to disclose that he is a consultant for Roche Diagnostics and GlaxoSmithKline. He was consulting on the preliminary development of an HSV vaccine
All of the relevant financial relationships listed for these individuals have been mitigated.
Content will not include any discussion of the unlabeled use of a product or a product under investigational use.
CDC did not accept financial or in-kind support from ineligible companies for this continuing education activity.
Jeanne Hoover 4102061156
jhoover6@jhmi.edu